(Q48502505)

12 February 2018

title

Abnormal expression of epidermal growth factor and its receptor in the forebrain and serum of schizophrenic patients (English)

1 reference

12 February 2018

0 references

0 references

Futamura T

1

1 reference

12 February 2018

Toyooka K

2

1 reference

12 February 2018

Iritani S

3

1 reference

12 February 2018

Niizato K

4

1 reference

12 February 2018

Nakamura R

5

1 reference

12 February 2018

Tsuchiya K

6

1 reference

12 February 2018

Someya T

7

1 reference

12 February 2018

Kakita A

8

1 reference

12 February 2018

Takahashi H

9

1 reference

12 February 2018

Nawa H

10

1 reference

12 February 2018

language of work or name

English

0 references

publication date

1 January 2002

1 reference

12 February 2018

published in

Molecular Psychiatry

1 reference

12 February 2018

volume

7

1 reference

12 February 2018

issue

7

1 reference

12 February 2018

page(s)

673-682

1 reference

12 February 2018

https://scigraph.springernature.com/pub.10.1038/sj.mp.4001081

exact match

0 references

cites work

Structure-function relationships for the EGF/TGF-alpha family of mitogens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001081

Roles of transforming growth factor-alpha and related molecules in the nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001081

Epidermal growth factor exerts neuronotrophic effects on dopaminergic and GABAergic CNS neurons: Comparison with basic fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001081

Epidermal growth factor and basic fibroblast growth factor promote the generation of long-term potentiation in the dentate gyrus of anaesthetized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001081

Trophic stimulation of cultured neurons from neonatal rat brain by epidermal growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001081

Neuronal and glial expression of heparin-binding EGF-like growth factor in central nervous system of prenatal and early-postnatal rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001081

Cellular localization of transforming growth factor-alpha mRNA in rat forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001081

The ontogeny of epidermal growth factor receptors during mouse development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001081

Epidermal growth factor receptor immunoreactivity in rat brain. Development and cellular localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001081

Localization of immunoreactive epidermal growth factor receptors in human nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001081

EGF enhances the survival of dopamine neurons in rat embryonic mesencephalon primary cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001081

Trophic actions of transforming growth factor alpha on mesencephalic dopaminergic neurons developing in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001081

A strain-independent postnatal neurodegeneration in mice lacking the EGF receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001081

A null mutation in TGF-alpha leads to a reduction in midbrain dopaminergic neurons in the substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001081

Effects of tryptophan and serotonin uptake inhibitors on behavior in male transgenic transforming growth factor alpha mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001081

Regulation of serotonin transporter gene expression in human glial cells by growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001081

Levels of transforming growth factor alpha (TGF-alpha) in human cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001081

Psychoneuroimmunology and the cytokine action in the CNS: implications for psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001081

The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001081

Cytokine and growth factor involvement in schizophrenia--support for the developmental model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001081

Growth factor-mediated Fyn signaling regulates alpha-amino-3- hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor expression in rodent neocortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001081

Plasma heparin-binding EGF-like growth factor levels in patients after partial hepatectomy as determined with an enzyme-linked immunosorbent assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001081

Expression of receptors for neuregulins, ErbB2, ErbB3 and ErbB4, in developing mouse cerebellum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001081

Structural brain imaging in schizophrenia: a selective review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001081

Immunoelectron microscope analysis of epidermal growth factor receptor (EGFR) in isolated Mytilus galloprovincialis (Lam.) digestive gland cells: evidence for ligand-induced changes in EGFR intracellular distribution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001081

The erbB/HER type 1 tyrosine kinase receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001081

Signal transduction by receptors with tyrosine kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001081

Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001081

The neurotrophic action and signalling of epidermal growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001081

Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001081

Glioblastoma-associated circulating monocytes and the release of epidermal growth factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001081

The neuropathology of schizophrenia. A critical review of the data and their interpretation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001081

Ectodomain shedding of epidermal growth factor receptor ligands is required for keratinocyte migration in cutaneous wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001081

Regulated shedding of syndecan-1 and -4 ectodomains by thrombin and growth factor receptor activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001081

Role of an anti-epidermal growth factor receptor in treating cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001081

Apoptosis and schizophrenia: is the tumour suppressor gene, p53, a candidate susceptibility gene?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001081

Schizophrenia as a brain disease. The dopamine receptor story

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001081

Epidermal growth factor as a local mediator of the neurotrophic action of vitamin B(12) (cobalamin) in the rat central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001081

7 January 2021

Epidermal Growth Factor and Basic Fibroblast Growth Factor Protect Dopaminergic Neurons from Glutamate Toxicity in Culture

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001081

7 January 2021

Alterations in brain monoamines and GABAA receptors in transgenic mice overexpressing TGF alpha

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001081

7 January 2021

Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001081

7 January 2021

Cytokines in affective disorders and schizophrenia: new clinical and genetic findings

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001081

7 January 2021

Phenotypic down-regulation of glutamate receptor subunit GluR1 in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001081

7 January 2021

Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001081

7 January 2021

Expression of NMDAR1, GluR1, GluR7, and KA1 glutamate receptor mRNAs is decreased in frontal cortex of "neuroleptic-free" schizophrenics: evidence on reversible up-regulation by typical neuroleptics.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001081

7 January 2021

Increases in CSF levels of interleukin-2 in schizophrenia: effects of recurrence of psychosis and medication status

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001081

7 January 2021

Glutamate receptors, microtubule associated proteins and developmental anomaly in schizophrenia: an hypothesis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001081

7 January 2021

Identifiers

DOI

10.1038/SJ.MP.4001081

1 reference

12 February 2018

Dimensions Publication ID

1036097330

0 references

1 reference

12 February 2018